Pertuzumab Recruiting Phase 4 Trials for HER2/Neu-positive Breast Cancer / Neoplasms, Breast / Breast Cancer / Malignant Neoplasm of Female Breast Treatment

IndicationsStatusPurposePhase
RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT05036005Neoadjuvant Ontruzant (SB3) in Patients With HER2-positive Early Breast Cancer: An Open-Label (NeoON)